| 20th Annual Cancer Progress The Premier Cancer Conference for Healthcare Executives March 10-11, 2009 The Westin New York Times Square |
|||||
|
Now in its 20th year, this hallmark
conference for pharmaceutical and biotechnology executives will continue to
provide cutting-edge presentations and candid panel discussions on breakthrough
concepts and developments which are critical to cancer drug development and
commercialization. The rapid growth in the number of
individuals alive with cancer is driving the demand for a new generation of
cancer therapeutics that improve patient outcomes. Discussions from leaders in
research and industry will cover emerging cancer targets, combination therapies,
developments in translational research, adaptive trial design, new research
directions in autophagy and metabolism and how these new agents are reshaping
treatment strategies.
Our
stellar faculty of presenters and panelists offers a mother-lode of information
and insights. Attendees receive a conference handbook and web-access to slides,
plus the annually-updated report on Oncology Drugs in the Pipeline. Plan
now to join us for strategic discussions, lively audience interactions and an
unsurpassed learning experience. Registration Form Last Year's Program (March, 2008)
|